|Bid||63.92 x 800|
|Ask||0.00 x 800|
|Day's range||63.64 - 64.57|
|52-week range||52.04 - 77.03|
|Beta (5Y monthly)||0.74|
|PE ratio (TTM)||11.58|
|Earnings date||05 Aug 2020|
|Forward dividend & yield||2.00 (3.08%)|
|Ex-dividend date||22 Apr 2020|
|1y target est||78.87|
Walgreens reports its Q3 FY20 financial results before the opening bell on Thursday, July 9. The question is should investors consider buying shares of the struggling pharmacy chain?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) closed the most recent trading day at $64.97, moving +0.85% from the previous trading session.
Shares in Cvs Health (NYQ:CVS) are currently trading at 64.42 but a key question for investors is how the economic uncertainty caused by Coronavirus will affec...
As U.S. employers grapple with trying to keep workers healthy and on the job amid fresh spikes in COVID-19 cases, CVS Health Corp has begun selling companies a diagnostic testing program. The unexpected surge in COVID-19 in states in the South and West has increased demand for testing workers on a regular basis, such as every two weeks or every month, said Troy Brennan, chief medical officer of the company, which operates pharmacies, a pharmacy benefit management (PBM) service and the Aetna insurance plan. More than 20 states including Florida, Arizona, and Texas, have reported an increase in COVID-19 cases and hospitalizations in recent weeks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Merck, CVS Health, Morgan Stanley, Applied Materials and Enterprise Products Partners
A wave of economic turmoil has washed through the stock market this year, sending investors fleeing for the perceived safety of dependable dividends. Finding t...
In the wake of nationwide protests in the U.S. against police brutality and racial inequality following the death of African American George Floyd last month, several companies have issued statements in support of the black community and set up funds to fight systemic racism. The change in policy at both companies comes after a Walmart customer complained the practice of locking up items that cater to people of color was discriminatory.
Quality and value are two of the most important drivers of stock market returns - yet many investors fail to take them seriously. At a time of deep economic un...
The job market is on the mend as lockdowns are eased and businesses gradual reopen. May numbers surpass all expectations, indicating the start of an economic revival from the coronavirus crisis.
And last month, the pharmacy giant started a test program that uses flying drones to deliver medicine to customers.
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
The markets have rallied since March's market crash but bargain hunters can still scoop up many cheap buys. CVS Health (NYSE: CVS) is a well-known name in healthcare and it isn't going anywhere. The pharmacy retailer's playing an important role during the COVID-19 pandemic: Not only is it helping people get their prescriptions, but it's assisting in testing people who are concerned they may have contracted the coronavirus.
Here are three companies in the out-of-favor retail and financial sectors that are solid names whose stocks are trading toward the bottom of their historical valuation ranges. The Home Depot (NYSE: HD) has been one of the essential retailers that have remained open during the COVID-19 crisis. This means more interest in fixer-uppers, which is good news for Home Depot.
Panic and uncertainty caused by the coronavirus disease 2019 (COVID-19) pandemic pushed the broad-based S&P 500 into its fastest bear market in history in March and eventually sent the widely followed stock index down 34% in just 33 calendar days. Despite never knowing when stock market corrections will present themselves, how long they'll last, or how steep the drop will be, every correction (and bear market) in history has proven to be an excellent buying opportunity for investors with a long-term mindset. What's more, you don't have to be rolling in dough to put your money to work in the stock market.